Looking forward to seeing you at BOS Manchester 2024
APC & VLE Therapeutics is looking forward to seeing you at Biotech Outsourcing Strategies on November 26-27th, 2024 in Manchester!
Cutting edge process development insights and news from APC.
APC & VLE Therapeutics is looking forward to seeing you at Biotech Outsourcing Strategies on November 26-27th, 2024 in Manchester!
A paradigm shift is underway—one that decouples process development from manufacturing, fundamentally changing how biopharma companies approach Chemistry, Manufacturing & Control (CMC) (learn more). This approach prioritizes a deep scientific understanding of processes and gives medicine developers full ownership of the data and insights required for flexible, efficient, and resilient manufacturing.
We’ve curated a list of key crystallization publications from the past 25 years, showcasing the research and breakthroughs that have defined our approach and expertise. These publications represent the culmination of decades of innovative work by APC’s crystallization experts, illustrating our ongoing impact in this field.
We will be at booth #99 Oct 29-31, 2024 in Barcelona to discuss your vaccine development and manufacturing challenges. Don't miss the technical presentation from our experts.
This study introduces a hybrid method combining the COSMO-RS model with machine learning to predict aqueous solubility at room temperature.
APC & VLE Therapeutics is looking forward to seeing you at BIO-Europe, in Sweden.
Explore these innovative approaches undertaken by APC in addressing the challenges of peptide crystallization .
Join us at Biomanufacturing World Summit, San Diego at booth # 13 to meet one-on-one and discuss your development and manufacturing challenges and our approach to accelerating your medicines through CMC hurdles.
Biostór and VLE Therapeutics have established a strategic alliance to deliver an end-to-end (E2E) cell banking solutions. This post outlines the detailed process of our collaboration, from initial consultation to final delivery, emphasizing the integration of our services.
Decentralized manufacturing in pharma, driven by ATMPs, is now extending to traditional large & small molecule medicines, transforming development & production.